Plain language summary
The gastrointestinal (GI) tract is colonised by millions of microorganisms, collectively called the gut microbiome. This microbiome has many biological functions including metabolism, energy regulation and communication with the immune system in the development of disease. The aim of this review was to summarise recent findings around the association between the gut microbiome and GI disease, exploring bacterial compositions, disease within the GI tract and approaches to restoring a disturbed microbiome. Recent findings support the view that the gut microbiome might serve as a future diagnostic and therapeutic target for GI disease. Based on these findings, the authors conclude that it is now evident that the human gut microbiome significantly contributes to both maintaining GI health and the development of GI disease.
Abstract
The gastrointestinal (GI) tract harbors a diverse and host-specific gut microbial community. Whereas host-microbe interactions are based on homeostasis and mutualism, the microbiome also contributes to disease development. In this review, we summarize recent findings connecting the GI microbiome with GI disease. Starting with a description of biochemical factors shaping microbial compositions in each gut segment along the longitudinal axis, improved histological techniques enabling high resolution visualization of the spatial microbiome structure are highlighted. Subsequently, inflammatory and neoplastic diseases of the esophagus, stomach, and small and large intestines are discussed and the respective changes in microbiome compositions summarized. Finally, approaches aiming to restore disturbed microbiome compositions thereby promoting health are discussed.
Methodological quality
Allocation concealment
:
Not applicable